Seeking Alpha

Myriad Genetics (MYGN): FQ2 EPS of $0.36 beats by $0.02. Revenue of $93M (+11%) vs. $91.6M....

Myriad Genetics (MYGN): FQ2 EPS of $0.36 beats by $0.02. Revenue of $93M (+11%) vs. $91.6M. Shares +7% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)